There is a dearth of literature specifically tackling the prevalence of DED before and during GLP-1 therapy, so in the absence of definitive prospective, randomized clinical trials, both eye care providers and GLP-1 prescribers should be aware of potential DED complications and how to ensure patients can experience all the benefits of these groundbreaking drugs without compromising ocular health
The doctor will review your full medical history, including any existing conditions such as thyroid issues, pancreatitis, or severe gastrointestinal disease, and current medications, to ensure your safety and the medication's effectiveness
The number of drinks a person has, along with their weight and sex, can affect their BAC levels
Do not combine with other stimulants, caffeinated products, MAO inhibitors, or Rauwolscine
7 Li study of normal human erythrocytes J Magn Reson 1987